The significance of PET/CT combined with machine learning models for the classification of lymphoma involvement and metastases in enlarged lymph nodes.
Source check: Source checked. Not independent scientific confirmation.
Finding: Original full text, Methods/Results: RF/SVM/ANN classified lymphoma involvement versus metastasis in 247 pathology-confirmed PET/CT nodes from 85 patients; RF AUC .942 with bootstrap/permutation assessment. Small, single-center internal evaluation. The result is reported in Frontiers in Oncology. The study does not establish generalization beyond its reported setting or prospective real-world benefit.
Technology: Random-forest, support-vector-machine and artificial-neural-network classifiers combined PET/CT metabolic and anatomical features to distinguish lymphoma-involved nodes from solid-tumor metastases.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Random-forest, support-vector-machine and artificial-neural-network classifiers combined PET/CT metabolic and anatomical features to distinguish lymphoma-involved nodes from solid-tumor metastases.
- Test and result
- Original full text, Methods/Results: RF/SVM/ANN classified lymphoma involvement versus metastasis in 247 pathology-confirmed PET/CT nodes from 85 patients; RF AUC .942 with bootstrap/permutation assessment. Small, single-center internal evaluation.
- Limitation / still unknown
- Independent replication and prospective real-world benefit are not established in the reviewed study.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2025.1643924/full · https://europepmc.org/article/MED/41098706
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.